Mori H, Itoh N, Yamada Y, Tamaya T
Asia Oceania J Obstet Gynaecol. 1989 Sep;15(3):281-9. doi: 10.1111/j.1447-0756.1989.tb00190.x.
To clarify the action mechanism of OK-432, OK-432 was intraperitoneally (i.p.) administered to 4 ovarian cancer patients with malignant ascites. In 2 of the 4 patients, 4 types of cytokines (tumor necrosis factor, interleukin 1 beta, interleukin 2, and interferon gamma) were induced in ascites after intraperitoneal injection of OK-432 (i.p. OK-432). In one of these patients, the ascitic supernatant after i.p. OK-432 significantly inhibited colony formation of autologous ascitic tumor cells; the amount of ascites decreased markedly, and the ascitic cytology became negative. In the other 2 patients, only interferon gamma was induced in ascites after i.p. OK-432. In these 2, ascitic supernatant did not inhibit colony formation of autologous ascitic tumor cells. These results indicated that i.p. OK-432 can induce various endogenous cytokines in malignant ascites and that these induced cytokines may contribute to the antitumor effect of i.p. OK-432.
为阐明溶链菌制剂(OK-432)的作用机制,对4例伴有恶性腹水的卵巢癌患者进行腹腔注射(i.p.)OK-432。4例患者中有2例,腹腔注射OK-432(腹腔内注射OK-432)后腹水中诱导出4种细胞因子(肿瘤坏死因子、白细胞介素1β、白细胞介素2和干扰素γ)。其中1例患者,腹腔内注射OK-432后的腹水上清液显著抑制自体腹水肿瘤细胞的集落形成;腹水量明显减少,腹水细胞学检查变为阴性。另外2例患者,腹腔内注射OK-432后腹水中仅诱导出干扰素γ。在这2例患者中,腹水上清液未抑制自体腹水肿瘤细胞的集落形成。这些结果表明,腹腔内注射OK-432可在恶性腹水中诱导多种内源性细胞因子,且这些诱导的细胞因子可能有助于腹腔内注射OK-432的抗肿瘤作用。